Lonza to acquire Genentech’s biologics manufacturing facility in Vacaville for $1.2bn

In a strategic move that significantly escalates its capacity in the biologics manufacturing landscape, Lonza, a key global player in manufacturing for the pharmaceutical, biotech, ... Read More